Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brough

Showing results (611-620 of 871) with videos related to

Pageof 88
Sort By:
Plos One|February 17, 2016
CDK1 Is a Synthetic Lethal Target for KRAS Mutant TumoursSara Costa-Cabral, Rachel Brough, Asha Konde, et al.
Epidemiology and Infection|February 10, 2022
Incursion of H5N8 high pathogenicity avian influenza virus (HPAIV) into gamebirds in EnglandSharon M Brookes, Karen L Mansfield, Scott M Reid, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2003
Hit-to-lead studies: the discovery of potent, orally bioavailable triazolethiol CXCR2 receptor antagonistsAndrew Baxter, Colin Bennion, Janice Bent, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 16, 2025
Open access online calculator predicts peanut allergic reactions with high accuracyHanipah Mears, Shriya A Sanghera, Henry T Bahnson, et al.
Disability and Rehabilitation|March 10, 2025
Setting me up or holding me back? Perspectives of people with spinal cord injury on rehabilitation supports at inpatient discharge and 3-months post-dischargeEmily Bray, Rachel Brough, Rachel Jones, et al.
Plos One|April 21, 2017
Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant TumoursSara Costa-Cabral, Rachel Brough, Asha Konde, et al.
Plos One|October 27, 2018
Correction: Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant TumoursSara Costa-Cabral, Rachel Brough, Asha Konde, et al.
Immunology and Cell Biology|August 26, 2016
P2X7 receptor-dependent tuning of gut epithelial responses to infectionSzu-Wei Huang, Catherine Walker, Joanne Pennock, et al.
Glia|February 12, 2022
LRRC8A is dispensable for a variety of microglial functions and response to acute strokeJames R Cook, Anna L Gray, Eloise Lemarchand, et al.
European Journal of Pharmacology|April 13, 2001
Characterisation using FLIPR of human vanilloid VR1 receptor pharmacologyD Smart, J C Jerman, M J Gunthorpe, et al.
Pageof 88

Showing results (611-620 of 871) with videos related to

Sort By:
Pageof 88
Plos One|February 17, 2016
CDK1 Is a Synthetic Lethal Target for KRAS Mutant TumoursSara Costa-Cabral, Rachel Brough, Asha Konde, et al.
Epidemiology and Infection|February 10, 2022
Incursion of H5N8 high pathogenicity avian influenza virus (HPAIV) into gamebirds in EnglandSharon M Brookes, Karen L Mansfield, Scott M Reid, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2003
Hit-to-lead studies: the discovery of potent, orally bioavailable triazolethiol CXCR2 receptor antagonistsAndrew Baxter, Colin Bennion, Janice Bent, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 16, 2025
Open access online calculator predicts peanut allergic reactions with high accuracyHanipah Mears, Shriya A Sanghera, Henry T Bahnson, et al.
Disability and Rehabilitation|March 10, 2025
Setting me up or holding me back? Perspectives of people with spinal cord injury on rehabilitation supports at inpatient discharge and 3-months post-dischargeEmily Bray, Rachel Brough, Rachel Jones, et al.
Plos One|April 21, 2017
Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant TumoursSara Costa-Cabral, Rachel Brough, Asha Konde, et al.
Plos One|October 27, 2018
Correction: Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant TumoursSara Costa-Cabral, Rachel Brough, Asha Konde, et al.
Immunology and Cell Biology|August 26, 2016
P2X7 receptor-dependent tuning of gut epithelial responses to infectionSzu-Wei Huang, Catherine Walker, Joanne Pennock, et al.
Glia|February 12, 2022
LRRC8A is dispensable for a variety of microglial functions and response to acute strokeJames R Cook, Anna L Gray, Eloise Lemarchand, et al.
European Journal of Pharmacology|April 13, 2001
Characterisation using FLIPR of human vanilloid VR1 receptor pharmacologyD Smart, J C Jerman, M J Gunthorpe, et al.
Pageof 88